ADVENTRX Pharmaceuticals, Inc. (AMEX: ANX), a biopharmaceutical company, is dedicated to in-licensing, developing and commercializing proprietary product candidates. Their key focus is on the treatment of cancer. The Company intends to enhance the performance and commercial potential of existing treatments by addressing issues related with these treatment regimens. For further information, visit the Company’s web site at www.adventrx.com.
- 17 years ago
QualityStocks
ADVENTRX Pharmaceuticals, Inc. (AMEX: ANX)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Files Patent for Preservative-Free Ketamine Formulation
NRx Pharmaceuticals (NASDAQ: NRXP) a clinical-stage biopharma company, has filed a patent application for NRX-100,…
-
ZDKL Champions World Peace Through Trade with Decentralized Tools for Global Commerce
Investor Brand Network ZDKL, a regulation-first blockchain project, has officially launched the Peace Through Trade…
-
QualityStocksNewsBreaks – Massimo Group (NASDAQ: MAMO) Ramps Up Innovation, Logistics to Power Growth
Massimo (NASDAQ: MAMO) is making strategic moves to actively enhance its position in the powersports and…